The Dog Urinary Catheter segmentation by application delineates three principal usage categories: surgical, diagnostic, and chronic management. Surgical applications dominate the market, accounting for roughly 45% of total revenue, as veterinarians employ catheters for intra‑operative bladder decompression and postoperative drainage in procedures such as cystotomies and urolith removals. Diagnostic usage contributes about 30%, driven by the need for precise urine sampling, pressure monitoring, and contrast studies in urological assessments. The remaining 25% is attributed to chronic management, where long‑term catheterization supports animals with neurogenic bladder dysfunction, severe urinary retention, or palliative care. Each segment's share reflects distinct cost structures, device turnover rates, and procurement cycles, collectively shaping the overall market size and informing supply chain allocation.